Align Technology | ALGN - Equity Capital And Reserves



Align Technology reported $3.79B in Equity Capital and Reserves for its fiscal quarter ending in March of 2025.


Equity Capital And Reserves Change Date
3M USD 4.29B 174M Jun/2025
Align Technology USD 3.79B 57.74M Mar/2025
Becton, Dickinson and Co. USD 25.47B 231M Jun/2025
Bruker USD 1.87B 33.9M Jun/2025
Cardinal Health USD -2781000000 167M Jun/2025
Charles River Laboratories USD 3.31B 119.03M Jun/2025
Cooper Companies USD 8.35B 64.9M Jul/2025
CVS Health USD 77.55B 622M Jun/2025
Danaher USD 52.33B 1.48B Jun/2025
Dentsply International USD 1.96B 50M Jun/2025
Dexcom USD 2.57B 306.5M Jun/2025
Henry Schein USD 3.44B 135M Jun/2025
Idexx Laboratories USD -4410277000 5.86B Jun/2025
Insulet USD 1.46B 132.2M Jun/2025
Integra LifeSciences USD 1.04B 485.48M Jun/2025
IQVIA Holdings USD 5.78B 199M Jun/2025
Masimo USD 1.04B 96.4M Jun/2025
McKesson USD -1967000000 107M Jun/2025
Mettler Toledo International USD -258793000 76.81M Jun/2025
Revvity USD 7.64B 29.74M Mar/2025
Solventum Corp 3.64B 383M Jun/2025
Stryker USD 21.19B 261M Jun/2025
Teleflex USD 4.24B 147.7M Jun/2025
Thermo Fisher Scientific USD 49.36B 227M Mar/2025
Veeva Systems USD 6.64B 427.44M Jul/2025
Waters USD 2.16B 197.42M Jun/2025
Zimmer Biomet Holdings USD 12.53B 130.5M Jun/2025
Zoetis USD 4.98B 322M Jun/2025